Eloxx Pharmaceuticals
(NASDAQ) ELOX
Eloxx Pharmaceuticals Financials at a Glance
Market Cap
$499.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$13.40M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-16577.59 (Low)
Dividend
$0.00
Beta (Volatility)
-16577.59 (Low)
Price
$11.90
Volume
133,335.06
Open
$12.25
Price
$11.90
Volume
133,335.06
Open
$12.25
Previous Close
$11.90
Daily Range
$10.51 - $13.99
52-Week Range
$10.51 - $17.50
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
-16577.59 (Low)
Price
$11.90
Volume
133,335.06
Open
$12.25
Previous Close
$11.90
Daily Range
$10.51 - $13.99
52-Week Range
$10.51 - $17.50
Estimated Earnings Date
Aug 10, 2026
ELOX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eloxx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Sumit Aggarwal, MBA
Website
www.eloxxpharma.comHeadquarters
Watertown, MA 02472, US
ELOX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
72.03%
Return on Capital
N/A
Return on Assets
-64.25%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$499.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
41.90K
Volume
133.34K
Avg. Volume
25.00K
Financials (TTM)
Gross Profit
-$373.00K
Operating Income
-$12.79M
EBITDA
-$12.05M
Operating Cash Flow
-$9.76M
Capital Expenditure
$0.00
Free Cash Flow
-$9.76M
Cash & ST Invst.
$6.36M
Total Debt
$0.00
Eloxx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$499.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$49.91K
N/A
Employees
10
N/A
Net Income
-$3.75M
+39.7%
EBITDA
-$3.73M
+33.0%
Quarterly Fundamentals
Total Cash
$6.36M
-67.3%
Total Debt
$0.00
-100.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-64.25%
N/A
Return on Invested Capital
66.15%
N/A
Free Cash Flow
-$5.45M
+20.0%
Operating Cash Flow
-$5.45M
+20.0%